Patents Assigned to AB-BIOTICS S.A.
  • Patent number: 11478423
    Abstract: A self-film-forming composition in powder form, a reconstituted formula and a kit for oral use are provided, which allow an adequate colonization of the probiotic in the oral cavities together with a sufficient residence time to allow beneficial effects against the pathogens related with oral conditions. Thus, the items provided are useful for the prevention and/or treatment of a condition related to alterations of the oral microbiota, and specifically for peri-implantitis. The self-film-forming composition in powder form comprises at least a gelifier agent and/or at least a bioadhesive agent, and at least one lactic acid bacteria strain.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: October 25, 2022
    Assignee: AB-BIOTICS, S.A.
    Inventors: Jonatan Santas Gutiérrez, Elisabet Lázaro Mallén, Jordi Cuné Castellana, Javier Mareque Mareque Bueno, Jose Luis Calvo Guirado
  • Patent number: 10850135
    Abstract: The present invention relates to lactic acid bacteria strains with the ability to tolerate antiseptics. The lactic acid bacteria strains have further the capacity to antagonize the growth of oral pathogens. Particularly, the lactic acid bacteria having these features belong to Pediococcus genus, more particularly to Pediococcus acidilactici species. Thus, the strains of the present invention are useful for compositions and products in the field of personal care, and 10 particularly, for oral care, as well as, for pharmaceutical products.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: December 1, 2020
    Assignee: AB-BIOTICS, S.A.
    Inventors: Jordi Cuñé Castellana, Jonathan Santas Gutiérrez
  • Patent number: 10265351
    Abstract: Provided is a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features and is useful in the amelioration of excessive crying in infants.
    Type: Grant
    Filed: August 7, 2014
    Date of Patent: April 23, 2019
    Assignees: AB-BIOTICS, S.A., VANPHARMA LABORATORIOS, S. A.
    Inventors: Jordi Cune Castellana, Elisabet Lazaro Mallen, Jordi Espadaler Mazo
  • Patent number: 10155015
    Abstract: The present disclosure is directed to methods of administering and compositions comprising Lactobacillus plantarum CECT 7478, Lactobacillus plantarum CECT 7485, and Pediococcus acidilactici CECT 7483 or a mutant or variant thereof. The compositions and methods are useful in the probiotic treatment of bowel diseases or conditions such as Inflammatory Bowel Disease, Irritable Bowel Syndrome, and abdominal distension and bloating.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: December 18, 2018
    Assignee: AB-Biotics S.A.
    Inventors: Jordi Espadaler Mazo, Jordi Cune Castellana
  • Publication number: 20180008652
    Abstract: The invention provides a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features. Thus, the bacterial composition is useful in the amelioration of excessive crying in infants. Particularly, Pediococcus pentosaceus cells are from the strain deposited as CECT 8330. The bacterial composition can be in the form of a food supplement, a medicament, an infant formula, an edible product and a food product. Particularly, the composition is in the form of an infant food supplement in the form of oily suspension.
    Type: Application
    Filed: July 18, 2017
    Publication date: January 11, 2018
    Applicants: AB-BIOTICS, S.A., VENPHARMA LABORATORIOS, S. A.
    Inventors: Jordi CUNE CASTELLANA, Elisabet LAZARO MALLEN, Jordi ESPADALER MAZO
  • Patent number: 9511102
    Abstract: The present invention provides a composition comprising an effective amount of Lactobacillus plantarum CECT 7481 and Lactobacillus brevis CECT 7480. Said strains exhibit various functional properties that make them suitable for their use in the improvement of oral health. Such properties include not only good antagonistic properties against oral pathogens, but also the ability to colonize the oral cavity and a low acidification profile. The invention also provides for the use of said composition as a probiotic and/or a medicament for oral health applications as well as products containing said composition.
    Type: Grant
    Filed: August 17, 2011
    Date of Patent: December 6, 2016
    Assignee: AB-BIOTICS S.A.
    Inventor: Jordi Cuñé Castellana
  • Publication number: 20160220620
    Abstract: The present disclosure is directed to methods of administering and compositions comprising Lactobacillus plantarum CECT 7478, Lactobacillus plantarum CECT 7485, and Pediococcus acidilactici CECT 7483 or a mutant or variant thereof. The compositions and methods are useful in the probiotic treatment of bowel diseases or conditions such as Inflammatory Bowel Disease, Irritable Bowel Syndrome, and abdominal distension and bloating.
    Type: Application
    Filed: April 21, 2016
    Publication date: August 4, 2016
    Applicant: AB-BIOTICS S.A.
    Inventors: Jordi Espadaler MAZO, Jordi Cune CASTELLANA
  • Publication number: 20160184371
    Abstract: Provided is a bacterial composition which comprises from 104 to 1012 cfu/g of Pediococcus pentosaceus cells which have the ability to induce the production of interleukin-10 to reduce inflammation in the intestinal tract among other features and is useful in the amelioration of excessive crying in infants
    Type: Application
    Filed: August 7, 2014
    Publication date: June 30, 2016
    Applicants: AB-BIOTICS, S.A., VENPHARMA LABORATORIOS, S. A.
    Inventors: Jordi CUNE CASTELLANA, Elisabet LAZARO MALLEN, Jordi ESPADALER MAZO
  • Patent number: 9192634
    Abstract: The present invention provides a composition comprising an effective amount of Lactobacillus plantarum CECT 7481 and Lactobacillus brevis CECT 7480. Said strains exhibit various functional properties that make them suitable for their use in the improvement of oral health. Such properties include not only good antagonistic properties against oral pathogens, but also the ability to colonize the oral cavity and a low acidification profile. The invention also provides for the use of said composition as a probiotic and/or a medicament for oral health applications as well as products containing said composition.
    Type: Grant
    Filed: May 5, 2015
    Date of Patent: November 24, 2015
    Assignee: AB-Biotics S.A.
    Inventor: Jordi Cũńe Castellana
  • Publication number: 20150273000
    Abstract: The present invention provides a composition comprising an effective amount of Lactobacillus plantarum CECT 7481 and Lactobacillus brevis CECT 7480. Said strains exhibit various functional properties that make them suitable for their use in the improvement of oral health. Such properties include not only good antagonistic properties against oral pathogens, but also the ability to colonize the oral cavity and a low acidification profile. The invention also provides for the use of said composition as a probiotic and/or a medicament for oral health applications as well as products containing said composition.
    Type: Application
    Filed: May 5, 2015
    Publication date: October 1, 2015
    Applicant: AB-BIOTICS S.A.
    Inventor: Jordi Cune Castellana
  • Patent number: 8668906
    Abstract: The invention relates to a composition comprising an effective amount of at least one of the strains selected from the group consisting of Lactobacillus plantarum CECT 7527, Lactobacillus plantarum CECT 7528, and Lactobacillus plantarum CECT 7529, These new strains have good probiotic features and are useful for the prevention and/or the treatment of cardiovascular disorders.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: March 11, 2014
    Assignee: Ab-Biotics S.A.
    Inventor: Jordi Cuñé Castellana
  • Publication number: 20120213753
    Abstract: The invention relates to a composition comprising an effective amount of at least one of the strains selected from the group consisting of Lactobacillus plantarum CECT 7527, Lactobacillus plantarum CECT 7528, and Lactobacillus plantarum CECT 7529, These new strains have good probiotic features and are useful for the prevention and/or the treatment of cardiovascular disorders.
    Type: Application
    Filed: September 28, 2010
    Publication date: August 23, 2012
    Applicant: AB-BIOTICS S.A.
    Inventor: Jordi Cuñé Castellana
  • Publication number: 20110195147
    Abstract: It is provided an iron-fortified food stuff comprising an iron source product in form of solid capsules, wherein the capsules comprise a core comprising iron alginate, and an outer layer comprising calcium alginate. The capsules are suitable both for fortifying hydrated and dehydrated food stuff and are characterized by an excellent loading capacity, as well as having a good stability under standard local conditions of storage and use. The iron-fortified food stuff of the invention serves to prevent the occurrence of iron deficiency or to reduce an iron deficiency in a human.
    Type: Application
    Filed: October 7, 2009
    Publication date: August 11, 2011
    Applicant: AB-BIOTICS S.A.
    Inventor: Galí Drudis Solé